TH

Thalassa Holdings Ltd.

A holding company active in property rentals and marine seismic & defense R&D.

THAL | IL

Overview

Corporate Details

ISIN(s):
VGG878801114
LEI:
2138002739WFQPLBEQ42
Country:
Virgin Islands (British)
Address:
FOLIO CHAMBERS, VG1110 ROAD TOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Thalassa Holdings Ltd. is a holding company engaged in international business activities. The company's operations are primarily focused on two segments: Rental Income, derived from its property interests, and Product Development. The Product Development segment concentrates on marine seismic and defense research and development, including geophysical project management, related services, and the supply of equipment. The company's strategic goal is to generate long-term shareholder value by deploying capital and expertise into investment opportunities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 9.9 KB
2025-10-29 11:39
M&A Activity
Thalassa Holdings Ltd: Trading Update
English 11.4 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 9.1 KB
2025-10-15 09:35
Board/Management Information
Thalassa Holdings Ltd: Thalassa Board reaches agreement with Newmark Security p…
English 10.5 KB
2025-10-08 08:30
Regulatory News Service
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 562.7 KB
2025-10-08 08:30
Major Shareholding Notification
Thalassa Holdings Ltd: Letter to Newmark Security plc (NWT) Shareholders
English 722.8 KB
2025-09-29 10:57
Board/Management Information
Thalassa Holdings Ltd: Surgical Innovations Group plc
English 7.9 KB
2025-09-29 08:30
Interim Report
Thalassa Holdings Ltd: 2025 Interim Results
English 408.7 KB
2025-09-29 08:30
Earnings Release
Thalassa Holdings Ltd: 2025 Interim Results
English 496.5 KB

Automate Your Workflow. Get a real-time feed of all Thalassa Holdings Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Thalassa Holdings Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Thalassa Holdings Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.